Translations:Diabetic nephropathy/30/en

Further reading

• "Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis". www.crd.york.ac.uk. Retrieved 2015-07-02.
• Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (January 2005). "Diabetic nephropathy: diagnosis, prevention, and treatment". Diabetes Care. 28 (1): 164–76. doi:10.2337/diacare.28.1.164. PMID 15616252.
• Tziomalos K, Athyros VG (2015). "Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis". The Review of Diabetic Studies. 12 (1–2): 110–8. doi:10.1900/RDS.2015.12.110. PMC 5397986. PMID 26676664.
• Kume S, Koya D, Uzu T, Maegawa H (2014). "Role of nutrient-sensing signals in the pathogenesis of diabetic nephropathy". BioMed Research International. 2014: 315494. doi:10.1155/2014/315494. PMC 4122096. PMID 25126552.
• Doshi SM, Friedman AN (August 2017). "Diagnosis and Management of Type 2 Diabetic Kidney Disease". Clinical Journal of the American Society of Nephrology. 12 (8): 1366–1373. doi:10.2215/CJN.11111016. PMC 5544517. PMID 28280116.